MEDIVIR AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.66 SEK | -1.48% |
|
-1.48% | -6.67% |
Chart calendar Medivir AB
4d06.w5gs66bAzkme-RlYadb4JA4qRH2RlN-z0B6wH-ZH0Cw.9eBbueORhHqznH4tXb6tTmpYIk-n0q_6tir1RZUUmx6gyFW99a-3DMGmLQ~28905f25807446760cdacb3103e7e4f6
Upcoming events on Medivir AB
Past events on Medivir AB
| 2024-04-09 | Oncology Forum |
| 2024-03-06 | Swiss Nordic Bio conference |
| 2024-03-06 | Vator Swiss Nordic Bio Conference |
| 2024-03-06 03:45 am | Life Science Day |
| 2024-02-21 | European Association for the Study of the Liver Liver Cancer Summit |
| 2024-02-15 08:00 am | Q4 2023 Earnings Call |
| 2024-02-15 02:30 am | Q4 2023 Earnings Release |
| 2024-01-24 09:20 am | Redeye Fight Cancer Meeting |
| 2024-01-23 08:00 am | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
| 2024-01-23 08:00 am | Fostrox + Lenvima® Phase 1b/2a Study Results Call |
| 2024-01-17 | ASCO Gastrointestinal Cancers Symposium |
| 2023-12-06 08:30 am | Carlsquare Equity Research Investor Day |
| 2023-12-03 | Rights Issue: 1 new share @ 2.65 SEK for 1 existing share |
| 2023-12-01 04:00 am | Extraordinary Shareholders Meeting |
| 2023-11-23 07:20 am | Redeye Life Science Day |
| 2023-11-23 04:10 am | Erik Penser Bank Company Event |
| 2023-11-08 08:00 am | Business Update Call |
| 2023-10-27 08:00 am | Q3 2023 Earnings Call |
| 2023-10-27 03:01 am | Q3 2023 Earnings Release |
| 2023-09-14 06:55 am | Pareto Securities Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 7,20 11,7 -38.46% | 39,4 22,5 75.5% | 35,7 27,4 30.53% | 6,20 4,10 51.22% | 9,00 3,07 193.48% | 26,8 |
|
EBITDA Million SEK | Released Forecast Spread | -119 -139 14.46% | -38,5 -57,3 32.75% | -59,5 -50,8 -17.24% | -84,8 -80,4 -5.47% | -88,7 -92,0 3.59% | -75,0 |
|
EBIT Million SEK | Released Forecast Spread | -126 -116 -8.25% | -42,9 -54,1 20.65% | -62,1 -54,3 -14.29% | -87,4 -79,1 -10.46% | -91,4 -90,5 -0.97% | -96,5 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -123 -114 -8.54% | -42,6 -53,6 20.47% | -62,6 -54,0 -15.85% | -88,8 -78,4 -13.22% | -89,3 -88,7 -0.73% | -96,4 |
|
Net income Million SEK | Released Forecast Spread | -123 -114 -8.53% | -42,6 -53,5 20.42% | -63,1 -54,5 -15.85% | -88,8 -71,7 -23.88% | -89,3 -88,7 -0.73% | -96,4 |
|
EPS SEK | Released Forecast Spread | -5,08 -4,68 -8.55% | -1,75 -2,21 20.69% | -1,20 -1,16 -3.15% | -1,59 -1,31 -21.68% | -1,48 -1,53 3.55% | -0,91 |
| Announcement Date | 13/02/20 | 26/02/21 | 15/02/22 | 15/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 11,4 9,69 17.65% | 18,8 19,1 -1.57% | 15,3 0,20 7550% | 0,90 4,00 -77.5% | 0,90 0,50 80% | 1,80 1,70 5.88% | 2,00 0,35 471.43% | 2,50 0,95 163.16% | 0,80 1,00 -20% | 2,60 1,00 160% | 3,30 1,80 83.33% | 1,00 0,50 100% | 4,70 0,40 1075% | 1,90 | 2,10 | 4,00 | 3,66 | 3,84 |
|
EBIT Million SEK | Released Forecast Spread | -22,1 -24,7 10.58% | -14,6 -26,6 45.21% | -18,7 -28,0 33.1% | -24,1 -23,1 -4.27% | -20,8 -17,5 -18.53% | -20,3 | -17,1 | -37,3 | -16,4 | -16,7 | ||||||||
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -36,1 -30,1 -19.93% | -25,4 -18,2 -39.56% | -24,3 -18,4 -32.07% | -32,7 -20,7 -57.97% | -23,1 -28,9 20.09% | -55,9 -35,8 -56.15% | -14,8 -27,1 45.43% | -18,1 -15,8 -14.56% | -18,9 -21,2 10.85% | -26,6 -19,5 -36.41% | -45,5 -34,1 -33.43% | -23,6 -22,5 -4.86% | -20,3 -21,1 3.9% | -20,2 | -17,0 | -37,1 | -16,4 | -16,6 |
|
Net income Million SEK | Released Forecast Spread | -36,1 -32,3 -11.76% | -25,5 -18,3 -39.34% | -24,3 -18,6 -30.65% | -32,7 -20,7 -57.97% | -23,1 -28,9 20.09% | -55,9 -35,8 -56.15% | -14,8 -27,1 45.43% | -18,1 -15,8 -14.56% | -18,9 -21,2 10.85% | -26,6 -19,5 -36.41% | -45,5 -34,1 -33.43% | -23,6 -22,5 -4.86% | -20,3 -21,1 3.9% | -20,2 | -17,0 | -37,1 | -16,4 | -16,6 |
|
EPS SEK | Released Forecast Spread | -1,49 -1,33 -12.03% | -0,57 -0,37 -54.05% | -0,44 -0,33 -33.33% | -0,59 -0,37 -59.46% | -0,42 -0,49 14.98% | -1,00 -0,64 -56.25% | -0,27 -0,51 46.64% | -0,32 -0,28 -14.29% | -0,34 -0,38 10.53% | -0,47 -0,35 -34.29% | -0,81 -0,61 -32.79% | -0,42 -0,35 -18.98% | -0,28 -0,37 23.5% | -0,24 | -0,20 | -0,44 | -0,18 | -0,18 |
| Announcement Date | 20/08/20 | 19/08/21 | 15/02/22 | 28/04/22 | 19/08/22 | 19/08/22 | 03/11/22 | 15/02/23 | 27/04/23 | 18/08/23 | 18/08/23 | 27/10/23 | 15/02/24 | - | - | - | - | - |
More events
Past sector events for Medivir AB
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ACELYRIN, INC.: Q4 2023 Earnings Release |
| 2024-03-28 04:02 pm | IMMUNOME, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MVIR B Stock
- Calendar Medivir AB
